Sundhedsstyrelsens nye retningslinier - DSOG

12
Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S Screeningpreventable
cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst.
2008;100:622-9. [Epub 2008 Apr 29].
13
Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, Køtlum JE, Ólafsdóttir E,
Pukkala E, Storm HH (Association of the Nordic Cancer Registries. Danish Cancer Society
(NORDCAN)): Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries,
Version 3.7, 2010. http://www.ancr.nu
14
Parkin DM, Whelan S, Ferlay J, Storm HH. Cancer Incidence in five Continents. Vol I to
VIII. IARC CancerBase No. 7, 2005.
15
Klint A, Tryggvadóttir L, Bray F, Gislum M, Hakulinen T, Storm HH, Engholm G
Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic
countries 1964-2003 followed up to the end of 2006. Acta Oncol. 2010;49:632-43.
16
Flannelly G, Monaghan J, Cruickshank M, Duncan I, Johnson J, Jordan J, Campbell M, Patnick J.
Cervical screening in women over the age of 50: results of a population-based multicentre study.
BJOG. 2004;111:362-8.
17
Rebolj M, van Ballegooijen M, Lynge E, Looman C, Essink-Bot ML, Boer R, Habbema D. Incidence
of cervical cancer after several negative smear results by age 50: prospective observational
study. BMJ 2009;338:b1354 [doi:10.1136/bmj.b1354].
18
McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC. Natural history
of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3:
a retrospective cohort study. Lancet Oncol 2008;9:425-34. [Epub 2008 Apr 11].
19
Sasieni P, Castañon A, Cuzick J. What is the right age for cervical cancer screening? Womens
Health (Lond Engl). 2010;6):1-4.
20
Kjær SK, Frederiksen K, Munk C, Iftner T Long-term absolute risk of cervical intraepithelial neoplasia
grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer
Inst. 2010;102:1478-88. [Epub 2010 Sep 14].
Kapitel 4, afsnit 2: Cytologi som primær screeningstest
1
Madsen EM. Smear-tagning. Ugeskr Laeger 2004;166:4246-7.
2
Lidang M, Hariri J, Nielsen K, Svanholm H, Ejersbo D, Nielsen JF. Anbefalede retningslinjer for
danskepatologiafdelinger vedrørende kvalitetssikring af screening mod livmoderhalskraft. Dansk
Selskab for Patologisk Anatomi og Cytologi, 2000.
3
Kjølby M, Bech M, Bjerregaard B, Kjellberg J, Lidang M, Sandahl P et al. Væskebaseret teknik og
udstrygningsteknik anvendt til screening for livmoderhalskræft i Danmark. MTV, Sundhedsstyrelsen,
2005.
Screening for livmoderhalskkræft. Anbefalinger 2011
74